cooperative trial neutron therapy soft tissue sarcomas started NUMBER NUMBER unselected previously irradiated patients NUMBER t3 tumours NUMBER recurrent tumours treated june NUMBER neutrons analysis cases mean period NUMBER months range NUMBER NUMBER months given report preliminary results presented NUMBER patients treated neutron boost showed substantially lower complication rate major results phase ii trial survival rate NUMBER years strongly dependent stage tumour NUMBER patients t1 tumours NUMBER NUMBER patients t2 tumours NUMBER NUMBER patients t3 tumours NUMBER survival rate NUMBER years strongly dependent surgery beginning radiotherapy NUMBER patients surgery clinical evidence residual tumour NUMBER NUMBER patients inoperable primary recurrent tumour NUMBER survival rate NUMBER patients recurrence neutron therapy NUMBER overall rate complications NUMBER neutron therapy NUMBER neutron boost therapy mean period NUMBER months range NUMBER NUMBER months follow follow